The AIDS Institute Comments on Arizona Medicaid Changes to Hepatitis C Prior Authorization Requirements

The AIDS Institute submitted comments on Wednesday, September 28, 2016 in response to Arizona Medicaid's proposed changes to their hepatitis C prior authorization policy. The biggest proposed changes included moving from an F score of F3 to F2 and loosening substance use remission restrictions from 6 months to 3 months. Our comments applauded them for taking steps in the right direction, but explained that there is no medical reason to have restrictions in those areas. The comments also encouraged the removal of prescriber restrictions.

Read our comments here.